lilly direct glp-1 The FDA approved a new pill from Eli on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Lilly's Zepbound price cut could

Psoriasis is a chronic skin condition that is linked not only to visible symptoms, but also to higher risks of cardiovascular issues such as heart attack, stroke and psychiatric issues including depression, anxiety and increased alcohol or substance use

Chris Serres: So I think the idea is, at least with the program we wrote about, is it was almost like the, the medications were like training wheels, right

E.BrethauerS

Horm Res

The company described the decision as part of its broader commitment to maintaining accessibility for patients seeking medically supervised care for metabolic and weight-related conditions

Institutional Approval Institutional review board (IRB) approval was not required for the publication of the case details